AlphaCentric Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,640	Closed	-$442K	–	277
2023 Q1	$442K	Buy	19,640 +1,000	+5%	+$22.5K	0.3%	93
2022 Q4	$392K	Buy	+18,640	New	+$392K	0.39%	84
2021 Q3	–	Sell	-61,500	Closed	-$897K	–	218
2021 Q2	$897K	Buy	+61,500	New	+$897K	0.24%	29